192 related articles for article (PubMed ID: 26818111)
21. Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Endo Y; Kumamoto H; Nakamura M; Sugawara S; Takano-Yamamoto T; Sasaki K; Takahashi T
Biol Pharm Bull; 2017; 40(6):739-750. PubMed ID: 28566618
[TBL] [Abstract][Full Text] [Related]
22. Role of intravenous dosage regimens of bisphosphonates in relation to other aetiological factors in the development of osteonecrosis of the jaws in patients with myeloma.
Jarnbring F; Kashani A; Björk A; Hoffman T; Krawiec K; Ljungman P; Lund B
Br J Oral Maxillofac Surg; 2015 Dec; 53(10):1007-11. PubMed ID: 26530732
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients.
Madrid C; Bouferrache K; Abarca M; Jaques B; Broome M
Oral Oncol; 2010 Jun; 46(6):468-70. PubMed ID: 20452814
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate related osteonecrosis of the jaws: a review.
Stepaniuk K
J Vet Dent; 2011; 28(4):277-81. PubMed ID: 22416626
[TBL] [Abstract][Full Text] [Related]
25. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
26. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
Mori M; Koide T; Matsui Y; Matsuda T
Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
[TBL] [Abstract][Full Text] [Related]
27. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
López-Cedrún JL; Sanromán JF; García A; Peñarrocha M; Feijoo JF; Limeres J; Diz P
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):874-9. PubMed ID: 23866309
[TBL] [Abstract][Full Text] [Related]
28. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
29. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
Yoneda T
Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.
Bedogni A; Saia G; Bettini G; Tronchet A; Totola A; Bedogni G; Ferronato G; Nocini PF; Blandamura S
Oral Oncol; 2011 May; 47(5):420-4. PubMed ID: 21439892
[TBL] [Abstract][Full Text] [Related]
31. Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
Thumbigere-Math V; Michalowicz BS; Hughes PJ; Basi DL; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
J Oral Maxillofac Surg; 2016 Apr; 74(4):738-46. PubMed ID: 26501428
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-related osteonecrosis of the jaw: what we have learned.
Tabari E; Sikavi C
Alpha Omegan; 2014; 107(2):8-15. PubMed ID: 25269218
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
[TBL] [Abstract][Full Text] [Related]
35. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
36. Effects of dexamethasone and nimesulide on bisphosphonate-related osteonecrosis of the jaw: An experimental study.
Oliveira CC; Barros Silva PG; Ferreira AEC; Gonçalves RP; Sousa FB; Mota MRL; Alves APNN
Arch Oral Biol; 2017 Nov; 83():317-326. PubMed ID: 28869827
[TBL] [Abstract][Full Text] [Related]
37. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
Eid A; Atlas J
Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
[TBL] [Abstract][Full Text] [Related]
38. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction.
Saia G; Blandamura S; Bettini G; Tronchet A; Totola A; Bedogni G; Ferronato G; Nocini PF; Bedogni A
J Oral Maxillofac Surg; 2010 Apr; 68(4):797-804. PubMed ID: 20307765
[TBL] [Abstract][Full Text] [Related]
39. [Research progress on bisphosphonate-related osteonecrosis of the jaws].
Jian P; Qizhang W; Jiyuan L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Feb; 35(1):29-36. PubMed ID: 28326724
[TBL] [Abstract][Full Text] [Related]
40. Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study.
Vescovi P; Campisi G; Fusco V; Mergoni G; Manfredi M; Merigo E; Solazzo L; Gabriele M; Gaeta GM; Favia G; Peluso F; Colella G
Oral Oncol; 2011 Mar; 47(3):191-4. PubMed ID: 21292541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
